Healthcare


 UBS Sector Shake-Up Leaves Australian Shares at a Crossroads

UBS Sector Shake-Up Leaves Australian Shares at a Crossroads

May 25, 2026 02:12 PM AEST| By Sam

Australia’s sharemarket is witnessing a major sector rotation as mining and healthcare gain momentum while banks, property, and consumer-linked sectors face growing economic pressure.

 Why This Aussie AI Healthcare Stock Is Expanding Fast

Why This Aussie AI Healthcare Stock Is Expanding Fast

May 25, 2026 02:09 PM AEST| By Sam

IMEXHS expanded its AI radiology technology deployment into Mexico, reflecting growing international demand for digital healthcare infrastructure and artificial intelligence-powered medical imaging solutions.

 Could 4DMedical’s Imaging Push Change Respiratory Care?

Could 4DMedical’s Imaging Push Change Respiratory Care?

May 25, 2026 02:06 PM AEST| By Sam

4DMedical’s CT:VQ platform is gaining visibility as respiratory imaging adoption discussions expand across hospitals, healthcare systems, and diagnostic markets, placing greater focus on clinical integration, regulatory progress, and healthcare innov...

 ASX 200 Stocks Face Fresh Market Pressure

ASX 200 Stocks Face Fresh Market Pressure

May 25, 2026 01:58 PM AEST| By Sam

Australian equities remained volatile as several major companies across healthcare, mining and retail sectors faced weaker outlooks, operational uncertainty and cautious sentiment amid changing economic conditions.

 CSL Limited (ASX:CSL) Operations Within the ASX 20

CSL Limited (ASX:CSL) Operations Within the ASX 20

May 25, 2026 01:47 PM AEST| By Sam

CSL Limited operates as a global biotherapeutics company across plasma-derived therapies, vaccines, and selected adjacent categories. As a constituent of the ASX 20 and the ASX 200, CSL maintains operational footprints across multiple international j...

 Why This ASX Healthcare Stock Is Suddenly Drawing Fresh Attention

Why This ASX Healthcare Stock Is Suddenly Drawing Fresh Attention

May 25, 2026 11:15 AM AEST| By Sam

Vitrafy Life Sciences gained fresh market attention after positive Phase II cryopreservation study results strengthened interest in its no-wash platelet preservation technology.

 Pacific Edge (ASX:PEB) Medicare Win Sparks Fresh Buzz

Pacific Edge (ASX:PEB) Medicare Win Sparks Fresh Buzz

May 25, 2026 10:58 AM AEST| By Sam

Pacific Edge gained renewed attention after a significant Medicare-related breakthrough strengthened discussion around its diagnostics expansion strategy and the growing role of precision medicine in global healthcare systems.

 ASX 200 Giant CSL Faces Fresh Growth Spotlight

ASX 200 Giant CSL Faces Fresh Growth Spotlight

May 25, 2026 10:40 AM AEST| By Sam

CSL continues attracting market attention as global healthcare demand, biotechnology innovation, and plasma therapy trends reinforce its position as one of Australia’s leading healthcare companies.

 Alcidion (ASX:ALC) Lands UK Deal That Turned Heads

Alcidion (ASX:ALC) Lands UK Deal That Turned Heads

May 25, 2026 10:33 AM AEST| By Sam

Alcidion strengthened its UK healthcare presence with a fresh hospital contract, highlighting growing global demand for digital clinical systems and renewed interest in Australian healthcare technology companies.

 Imugene Advances Cancer Research With Azer-cel Progress

Imugene Advances Cancer Research With Azer-cel Progress

May 22, 2026 04:21 PM AEST| By Sam

Imugene strengthens its position in cancer research after releasing encouraging azer-cel clinical trial findings for advanced blood cancer patients in the evolving immunotherapy landscape.

 Why ASX Healthcare Stocks Are Back in Focus

Why ASX Healthcare Stocks Are Back in Focus

May 22, 2026 03:53 PM AEST| By Sam

ASX healthcare shares regain attention as emerging companies advance innovation in kidney disease, cancer care, sleep health, imaging technology and gut health across global markets.

 Why Mayne Pharma’s Court Victory Is Turning Heads

Why Mayne Pharma’s Court Victory Is Turning Heads

May 22, 2026 03:09 PM AEST| By Sam

Mayne Pharma returned to market focus after securing a major court costs order amid growing attention on healthcare regulation and pharmaceutical sector governance.

 Why This Healthcare Tech Deal Is Turning Heads

Why This Healthcare Tech Deal Is Turning Heads

May 22, 2026 12:32 PM AEST| By Sam

Alcidion attracted renewed market attention after expanding through a Telstra Health deal, highlighting growing momentum across healthcare technology and digital clinical systems.

 Why These ASX 200 Shares Are Back In The Spotlight

Why These ASX 200 Shares Are Back In The Spotlight

May 22, 2026 11:16 AM AEST| By Sam

CSL, Megaport and Treasury Wine Estates are attracting renewed market attention as investors search for ASX recovery opportunities.

 Why Oceania Healthcare’s Dividend Pause Is Raising Eyebrows

Why Oceania Healthcare’s Dividend Pause Is Raising Eyebrows

May 22, 2026 10:06 AM AEST| By Sam

Oceania Healthcare improved earnings, reduced debt and strengthened care margins, but ongoing cash flow pressure continues delaying dividend payments.

 IXICO Expands Reach in Neuroscience Research Space

IXICO Expands Reach in Neuroscience Research Space

May 21, 2026 07:44 PM AEST| By Vivek Singh

IXICO (LSE:IXI) advances its neuroscience imaging capabilities with fresh healthcare research contracts supporting Alzheimer’s and Huntington’s disease development programmes.

 Avecho Biotechnology Advances Insomnia Program Momentum

Avecho Biotechnology Advances Insomnia Program Momentum

May 21, 2026 04:45 PM AEST| By Sam

Avecho Biotechnology advances its insomnia treatment program after completing a major clinical trial milestone, strengthening attention on Australia’s evolving cannabidiol healthcare market.

 ASX Healthcare Stocks: Why AFT’s Revenue Ambition Is Turning Heads

ASX Healthcare Stocks: Why AFT’s Revenue Ambition Is Turning Heads

May 21, 2026 02:21 PM AEST| By Sam

AFT Pharmaceuticals gained market attention after record earnings and a fresh revenue direction, highlighting healthcare innovation, and expanding international operations within the pharmaceutical sector.

 AFT Pharmaceuticals Profit Surges As Global Expansion Gains Momentum

AFT Pharmaceuticals Profit Surges As Global Expansion Gains Momentum

May 21, 2026 01:26 PM AEST| By Sam

Highlights,AFT Pharmaceuticals reported strong profit growth supported by rising revenue.,Expansion across international healthcare markets continued gaining traction.,Management expects further earnings and sales momentum during the current financia...

 Avecho ASX 200 Reports Progress in Insomnia Clinical Trial

Avecho ASX 200 Reports Progress in Insomnia Clinical Trial

May 21, 2026 01:10 PM AEST| By Sam

Avecho completed the treatment phase for its late-stage insomnia study while advancing interim review procedures linked to pharmaceutical development activities.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.